epitope

In theory you can have cancerous cells that are (at least in the epitope-space) indistinguishable from normal cells.

The most common cause is mutations causing unrelated proteins to mimic an epitope (binding site) of the biomarker protein.

Environmental exposures like smoking (the data says in shared epitope + individuals) raise that risk significantly.

What if it changes the epitope and evades the vaccine induced antibody(ies), again!?!

They have a new approach, Designerbodies™, which allow predefined epitope-paratope interactions.

If something binds on the test part of the strip it has the right epitope and there are no other viruses yet with these patterns.

Not being snarky, just very concerned.) And might I also ask: Any concerns about accidentally inducing an autoimmune disorder with that antigen/epitope?

I can easily find plenty of papers using ML for HIV epitope analysis.

If you activate the immune system defenses in the presence of a non-self epitope (or sometimes even self in autoimmune diseases), you're going to pick up antigen recognition.

Can EPS3.9 cause pyroptosis cause IFN-I cause epitope spreading for cancer treatment?

This is often hindered by chemotherapy, although in the best case scenario, if the chemo is effective then it can lead to antigen uptake by local immune cells (epitope spread) which leads to a cascade of immune activity to clear the tumors.

Essentially since the copy mechanism is leaky and produces multiple variants, and the immune system produces a selective response, how do you know that the single epitope you vaccinate against will be sufficient?

Telomerase is present in 85-90% of all cancers, across the stages of the disease.” It’s a protein epitope vaccine against a normal human protein.

"Current research suggests that several mechanisms, such as molecular mimicry, epitope spreading, and bystander activation, can cause viral-induced autoimmunity."

Well, the actual title is "Sensitization of tumours to immunotherapy by boosting early type-I interferon responses enables epitope spreading." This is just the reduced version for mass consumption.

If you are looking for a common denominator across controllers broadly, the selective epitope targeting explanation seems to make the most sense to us and does not appear to be constrained by anything but the individual's HLA type which essentially determines what epitopes a particular individual's immune system can "see."

Epitope recognition is powered by a biological RNG (somatic hypermutation) and evolves at runtime via the process of somatic / V(D)J chain recombination.